Corcept Therapeutics (CORT) Tax Provisions (2017 - 2026)
Corcept Therapeutics recorded quarterly Tax Provisions of -$13.0 million in Q1 2026, up 9.9% quarter-over-quarter from -$14.4 million in Q4 2025, and down 18.84% year-over-year from -$16.0 million in Q1 2025.
Corcept Therapeutics' Tax Provisions history runs 10 years deep, the most recent figure standing at -$13.0 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 18.84% year-over-year to -$13.0 million; the TTM figure through Mar 2026 stood at -$35.2 million (down 1765.75% YoY), while the FY2025 annual figure was -$33.2 million, down 263.62% from the prior year.
- Tax Provisions came in at -$13.0 million for Q1 2026 at Corcept Therapeutics, up from -$14.4 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $7.7 million in Q4 2022 to a low of -$14.4 million in Q4 2025.
- A 5-year average of $434882.4 and a median of $4.1 million in 2022 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions surged 412.16% in 2023 and tumbled 1284.35% in 2025, its largest moves.
- Corcept Therapeutics' Tax Provisions stood at $7.7 million in 2022, then decreased by 29.4% to $5.4 million in 2023, then tumbled by 77.59% to $1.2 million in 2024, then sank by 1284.35% to -$14.4 million in 2025, then gained by 9.9% to -$13.0 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$13.0 million, -$14.4 million, and -$4.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn | -12.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.95 Mn |
| Dec 31, 2025 | -14.38 Mn |
| Sep 30, 2025 | -4.43 Mn |
| Jun 30, 2025 | -3.46 Mn |
| Mar 31, 2025 | -10.90 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 5.70 Mn |
| Jun 30, 2024 | 6.10 Mn |
| Mar 31, 2024 | 7.20 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 5.01 Mn |
| Jun 30, 2023 | 5.40 Mn |
| Mar 31, 2023 | 2.60 Mn |
| Dec 31, 2022 | 7.67 Mn |
| Sep 30, 2022 | -1.60 Mn |
| Jun 30, 2022 | 4.70 Mn |
| Mar 31, 2022 | 4.10 Mn |
| Dec 31, 2021 | 4.69 Mn |
| Sep 30, 2021 | 5.80 Mn |
| Jun 30, 2021 | 5.53 Mn |
| Mar 31, 2021 | -3.55 Mn |
| Dec 31, 2020 | 4.79 Mn |
| Sep 30, 2020 | 3.72 Mn |
| Jun 30, 2020 | 7.90 Mn |
| Mar 31, 2020 | 9.10 Mn |
| Dec 31, 2019 | 7.08 Mn |
| Sep 30, 2019 | 8.00 Mn |
| Jun 30, 2019 | 5.60 Mn |
| Mar 31, 2019 | 1.80 Mn |
| Dec 31, 2018 | 3.93 Mn |
| Sep 30, 2018 | 6.00 Mn |
| Jun 30, 2018 | 3.00 Mn |
| Mar 31, 2018 | 3.80 Mn |
| Dec 31, 2017 | -76.45 Mn |
| Sep 30, 2017 | -48,000.00 |
| Jun 30, 2017 | 50,000.00 |
| Mar 31, 2017 | 127,000.00 |